Mannkind (MNKD) Total Non-Current Liabilities (2012 - 2026)

Mannkind (MNKD) reported Total Non-Current Liabilities of $798.5 million for Q1 2026, down 4.73% quarter-over-quarter from $838.1 million in Q4 2025.

Mannkind (MNKD) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

Mannkind (MNKD) has 15 years of Total Non-Current Liabilities data on file, last reported at $798.5 million in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $798.5 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $798.5 million (changed N/A YoY), and the FY2025 annual result was $838.1 million, changed N/A from the prior year.
  • Total Non-Current Liabilities fell to $798.5 million in Q1 2026 per MNKD's latest filing, from $838.1 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $838.1 million in Q4 2025 and troughed at -$55000.0 in Q4 2022.
  • A 5-year average of $526.4 million and a median of $553.5 million in 2023 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities slumped 100.01% in 2022, then jumped 265107.27% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at -$55000.0 in 2022, then jumped by 265107.27% to $145.8 million in 2023, then soared by 387.67% to $710.8 million in 2024, then increased by 17.91% to $838.1 million in 2025, then fell by 4.73% to $798.5 million in 2026.
  • Business Quant data shows MNKD's Total Non-Current Liabilities at $798.5 million in Q1 2026, $838.1 million in Q4 2025, and $710.8 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 798.45 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 798.45 Mn
Dec 31, 2025 838.09 Mn
Mar 31, 2024 710.79 Mn
Dec 31, 2023 145.75 Mn
Sep 30, 2023 572.05 Mn
Jun 30, 2023 573.85 Mn
Mar 31, 2023 553.48 Mn
Dec 31, 2022 -55,000.00
Sep 30, 2022 531.46 Mn
Jun 30, 2022 532.77 Mn
Mar 31, 2022 533.33 Mn
Dec 31, 2021 525.56 Mn
Sep 30, 2021 422.61 Mn
Jun 30, 2021 436.17 Mn
Mar 31, 2021 488.25 Mn
Dec 31, 2020 284.88 Mn
Sep 30, 2020 276.25 Mn
Jun 30, 2020 277.95 Mn
Mar 31, 2020 275.00 Mn
Dec 31, 2019 282.25 Mn